Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer

Given the established individual activity of docetaxel and ifosfamide in anthracycline pretreated advanced breast cancer, the present phase I–II study aimed to define the maximum tolerated dose (MTD), the dose-limiting toxicities (DLTs), and activity of the docetaxel–ifosfamide combination in this s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kosmas, C, Tsavaris, N, Malamos, N, Stavroyianni, N, Gregoriou, A, Rokana, S, Polyzos, A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2003
Onderwerpen:
Clinical
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747562/
https://ncbi.nlm.nih.gov/pubmed/12698179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600887
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items